In this issue:
Integrated image-based deep learning and language models for primary diabetes care
Effects of semaglutide on CKD in type 2 diabetes
Intensive glycaemic control in type 2 diabetes out to 24 years
Behaviour change techniques for diabetes self-management mobile apps
Dementia risk after SGLT-2 or DPP-4 inhibitor initiation in type 2 diabetes
Meat consumption increases type 2 diabetes risk
Once-weekly semaglutide in obesity and prediabetes
Early findings from the UK NHS Type 2 Diabetes Path to Remission program
Incidence of diabetes after SARS-COV- 2 infection, and implications of vaccination
Impact of GLP-1 receptor agonists on cardiorenal benefits of SGLT-2 inhibitors
Please login below to download this issue (PDF)